Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

PURPOSE: We conducted a post hoc analysis of the vandetanib phase III trial involving patients with advanced medullary thyroid cancer (MTC) to assess the efficacy and safety of vandetanib in patients with progressive and symptomatic MTC. The primary objective of the analysis was to determine progres...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Oncol
Autori principali: Kreissl, Michael C., Bastholt, Lars, Elisei, Rossella, Haddad, Robert, Hauch, Ole, Jarząb, Barbara, Robinson, Bruce, Colzani, Raffaella, Foster, Meredith, Weiss, Richard, Schlumberger, Martin
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2020
Soggetti:
ORIGINAL REPORTS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430220/
https://ncbi.nlm.nih.gov/pubmed/32584630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.02790
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi